Page results
-
We offer weekly neuro-rehabilitation assessment clinics where our patients are assessed by a multidisciplinary team.
-
Zero carbon, virtual appointments, specialist advice in primary care settings, thousands using online services, remote monitoring and digitising admin tasks: these are just some of the ways we will achieve patient-centred, integrated, excellent care for our patients as set out in our new outpatient strategy.
-
There are just a few days left to share your views as part of a public consultation on proposed changes to how and where maternity, neonatal, and children’s surgical services could be provided in North Central London. The consultation closes on Sunday, 17 March 2024.
-
The latest copy of our magazine, Charity Matters is out now, available to read online or in hard copy in and around sites at UCLH hospitals.
-
This information has been written for patients who are having total body irradiation (TBI) for a haematological cancer.
-
This page provides information about endovascular treatments which use a trans-venous approach in the NHNN angiography suite.
-
This page is intended for patients who suffer from laryngeal dystonia (formerly known as spasmodic dysphonia) who might benefit from this therapy.
-
This page is for patients who are about to start a course of radiotherapy to the prostate/prostate bed.
-
This page answers common questions about high-intensity focused ultrasound (HIFU) treatment for the prostate.
-
This page explains what extravasation is, and outlines the steps we take when it occurs.
File results
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment
-
FOI/2022/0540 - Electronic patient record
-
FOI/2022/0541 - Serious Incidents Level 2 deaths/ serious harm